April 8th 2020
Casey M. Cosgrove, MD, discusses the utilization of PARP inhibition in ovarian cancer.
January 24th 2020
Casey M. Cosgrove, MD, discusses the approval of niraparib in advanced ovarian cancer.
December 18th 2019
Casey M. Cosgrove, MD, gynecologic oncologist, The Ohio State University Comprehensive Cancer Center–James, and assistant professor, Department of Gynecologic Oncology, The Ohio State University College of Medicine, discusses retreatment with PARP inhibitors in recurrent ovarian cancer.